Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.
Cisternas, Marcela
Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al. [electronic resource] - Arthritis and rheumatism Nov 2002 - 3107-8; author reply 3108-9 p. digital
Publication Type: Case Reports; Comment; Letter
0004-3591
10.1002/art.10488 doi
Adult
Antibodies, Monoclonal--administration & dosage
Antirheumatic Agents--administration & dosage
Arthritis, Psoriatic--drug therapy
Guillain-Barre Syndrome--etiology
Humans
Infliximab
Male
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al. [electronic resource] - Arthritis and rheumatism Nov 2002 - 3107-8; author reply 3108-9 p. digital
Publication Type: Case Reports; Comment; Letter
0004-3591
10.1002/art.10488 doi
Adult
Antibodies, Monoclonal--administration & dosage
Antirheumatic Agents--administration & dosage
Arthritis, Psoriatic--drug therapy
Guillain-Barre Syndrome--etiology
Humans
Infliximab
Male
Tumor Necrosis Factor-alpha--antagonists & inhibitors